NO980553L - Endotelinantagonist - Google Patents

Endotelinantagonist

Info

Publication number
NO980553L
NO980553L NO980553A NO980553A NO980553L NO 980553 L NO980553 L NO 980553L NO 980553 A NO980553 A NO 980553A NO 980553 A NO980553 A NO 980553A NO 980553 L NO980553 L NO 980553L
Authority
NO
Norway
Prior art keywords
endothelin antagonist
alpha
chain
carbon atoms
active ingredient
Prior art date
Application number
NO980553A
Other languages
English (en)
Norwegian (no)
Other versions
NO980553D0 (no
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Publication of NO980553D0 publication Critical patent/NO980553D0/no
Publication of NO980553L publication Critical patent/NO980553L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S502/00—Catalyst, solid sorbent, or support therefor: product or process of making
    • Y10S502/50—Stabilized
    • Y10S502/503—Crush strength

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO980553A 1996-06-10 1998-02-09 Endotelinantagonist NO980553L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14716696 1996-06-10
JP1019197 1997-01-23
PCT/JP1997/001892 WO1997047595A1 (en) 1996-06-10 1997-06-04 Endothelin antagonist

Publications (2)

Publication Number Publication Date
NO980553D0 NO980553D0 (no) 1998-02-09
NO980553L true NO980553L (no) 1998-04-07

Family

ID=26345421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980553A NO980553L (no) 1996-06-10 1998-02-09 Endotelinantagonist

Country Status (14)

Country Link
US (2) US6242485B1 (da)
EP (1) EP0857718B1 (da)
JP (1) JP3187438B2 (da)
KR (1) KR19990036322A (da)
CN (3) CN102126998B (da)
AT (1) ATE222237T1 (da)
CA (1) CA2229183C (da)
DE (1) DE69714698T2 (da)
DK (1) DK0857718T3 (da)
ES (1) ES2182088T3 (da)
NO (1) NO980553L (da)
PT (1) PT857718E (da)
TW (1) TW418188B (da)
WO (1) WO1997047595A1 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69832513T2 (de) * 1997-09-09 2006-07-13 Duke University Aromatische c16-c20-substituierte tetrahydro-prostaglandinen verwendbar wie fp agoniste
HUP0004427A3 (en) * 1997-09-09 2001-09-28 Procter & Gamble Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
BR9811774A (pt) * 1997-09-09 2000-08-29 Procter & Gamble Tetraidroprostaglandinas aromáticas substituìdas por c16-c20 úteis como agonistas fp
PT978284E (pt) 1997-11-28 2008-10-07 Sucampo Ag Utilização de compostos 15-ceto-prostaglandina-e como antagonistas da endotelina
ES2232434T3 (es) 1999-03-05 2005-06-01 Duke University Analogos de prostaglandinas c-16 fp selectivas insaturadas.
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
ATE387204T1 (de) * 2001-05-18 2008-03-15 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
WO2003020283A2 (en) * 2001-08-29 2003-03-13 Novartis Ag Method for treating diabetic retinopathy
CA2458471C (en) 2001-08-31 2012-07-31 Sucampo Ag Prostaglandin analogs as chloride channel opener
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
JP2006504406A (ja) 2002-06-28 2006-02-09 セントカー・インコーポレーテツド 哺乳動物のｃｈ１欠失ミメティボディ、組成物、方法および使用
US8114911B2 (en) * 2002-10-23 2012-02-14 Sucampo Ag Prostaglandin compounds for the treatment of obesity
ES2591252T3 (es) 2002-12-27 2016-11-25 Sucampo Ag Derivados de prostaglandinas para tratar el síndrome de colon irritable y/o la dispepsia funcional
JP5294559B2 (ja) * 2003-07-03 2013-09-18 スキャンポ・アーゲー クロライドチャンネルオープナーとしてプロスタグランジンアナログを含む腸溶性組成物
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
KR20120005052A (ko) 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
EP1841433B1 (en) 2005-01-27 2011-11-30 Sucampo AG Composition for treating central nervous system disorders
AR055038A1 (es) 2005-03-04 2007-08-01 Sucampo Ag Metodo y compuesto para tratar enfermedades vasculares perifericas
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
CN102293774A (zh) * 2005-03-31 2011-12-28 旭硝子株式会社 前列腺素F2α衍生物的应用
KR20140069182A (ko) * 2005-04-12 2014-06-09 수캄포 아게 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자 펌프 억제제의 병용
PT1978944E (pt) * 2006-01-24 2012-11-26 Sucampo Ag Formulação em cápsula de gelatina mole
KR20140147142A (ko) 2006-01-24 2014-12-29 가부시키가이샤 아루떼꾸 우에노 바이-사이클릭 화합물을 함유하는 약학적 조성물 및 바이-사이클릭 화합물의 안정화 방법
CN102391237B (zh) * 2006-02-07 2014-07-16 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
BRPI0708891A2 (pt) 2006-03-13 2011-06-28 R Tech Ueno Ltd composição aquosa
WO2007119214A2 (en) * 2006-04-13 2007-10-25 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
CA2639240A1 (en) * 2008-08-29 2010-02-28 Alphora Research Inc. Prostaglandin synthesis and intermediates for use therein
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
JP2014510022A (ja) 2011-04-07 2014-04-24 スキャンポ・アーゲー 眼精疲労の処置方法
BR112014002712A8 (pt) 2011-08-05 2017-06-20 Sucampo Ag método para tratamento da esquizofrenia
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
GB201418567D0 (en) * 2014-10-20 2014-12-03 Syngenta Participations Ag Improvements in or relating to organic compounds
US20170020890A1 (en) 2015-06-19 2017-01-26 Sucampo Ag Pharmaceutical composition comprising fatty acid derivative

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853951A (en) * 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
US4018811A (en) * 1972-02-11 1977-04-19 American Cyanamid Company 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof
CA1027118A (en) * 1972-04-03 1978-02-28 Martin J. Weiss 3-alkyl-2-(6-carboxyhexyl) cyclopentanones and esters and salts thereof
US3981868A (en) 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
US3974195A (en) 1974-10-02 1976-08-10 The Upjohn Company 2A,2B-Dihomo-15-alkyl-PGF2.sub.α analogs
US4026909A (en) 1975-07-14 1977-05-31 The Upjohn Company Cis-13-PGF2.sub.α analogs
US4166187A (en) 1977-04-11 1979-08-28 The Upjohn Company 9-deoxy-9-methylene-16-phenyl-5,6-didehydro-pgf2 or 4,4,5,5-tetradehydro-pgf1 compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5140271A (en) 1989-12-26 1992-08-18 Texaco Inc. Watercut means and method with debris reducing test cell
US5292754A (en) 1990-03-08 1994-03-08 Shionogi & Co., Ltd. Treatment for hypertension or glaucoma in eyes
TW249226B (da) 1990-04-04 1995-06-11 Aderk Ueno Kk
BE1004080A6 (fr) * 1990-04-18 1992-09-22 Centre Rech Metallurgique Procede pour le controle automatique de la qualite d'un composant de carrosserie automobile.
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
JPH07113012B2 (ja) * 1991-01-29 1995-12-06 株式会社アールテック・ウエノ 新規１５−ケト−プロスタグランジン類
DK0503887T3 (da) * 1991-03-14 1996-09-16 R Tech Ueno Ltd Fremme af sårheling med 15-ketoprostaglandinforbindelser

Also Published As

Publication number Publication date
AU716176B2 (en) 2000-02-17
CN102126998B (zh) 2013-06-12
CN101085756A (zh) 2007-12-12
US6242485B1 (en) 2001-06-05
ES2182088T3 (es) 2003-03-01
TW418188B (en) 2001-01-11
AU3047897A (en) 1998-01-07
WO1997047595A1 (en) 1997-12-18
CN101085756B (zh) 2011-03-02
DE69714698T2 (de) 2002-12-05
CN1198737A (zh) 1998-11-11
DE69714698D1 (de) 2002-09-19
ATE222237T1 (de) 2002-08-15
EP0857718A1 (en) 1998-08-12
CA2229183C (en) 2008-11-04
KR19990036322A (ko) 1999-05-25
JP3187438B2 (ja) 2001-07-11
CN102126998A (zh) 2011-07-20
EP0857718A4 (en) 1999-07-28
DK0857718T3 (da) 2002-12-16
CA2229183A1 (en) 1997-12-18
PT857718E (pt) 2002-11-29
US6452039B1 (en) 2002-09-17
NO980553D0 (no) 1998-02-09
EP0857718B1 (en) 2002-08-14
CN100337632C (zh) 2007-09-19

Similar Documents

Publication Publication Date Title
DK0857718T3 (da) Endothelinantagonist
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
MY126559A (en) Fungicidal 2-methoxybenzophenones
PT925298E (pt) Derivados 6,6-hetero-biciclicos substituidos
ID25548A (id) Senyawa-senyawa heterosiklik spiroazabisiklik terbaru
FI954651A7 (fi) Mahdollisesti substituoidut 6,8-kinoliinit
FI960156A7 (fi) Bentsyylioksikinuklidiinit aineet P antagonisteina
NO996429D0 (no) 2-substituerte 4,5-diarylimidazoler
IT1271014B (it) 3-aril-benzofuranoni come agenti stabilizzanti
DE69803907D1 (de) Fungizide 2-Methoxybenzophenone
ID24583A (id) Turunan-turunan 1,2,3,4-tetrahidronaftalena tersubstitusi
DE69300694D1 (de) Desinfizierende Zusammensetzungen.
EP0671911A4 (en) CARBOXYPEPTIDYL DERIVATIVES AS AN ANTIDEGENERATIVE ACTIVE SUBSTANCES.
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
HRP20010238B1 (en) 2-methyl-thieno-benzodiazepine formulation
DE69818261D1 (en) Hydroxycyclopentanone
EP1008345A4 (en) ANTI-ALLERGIC AGENTS
DK1073447T3 (da) N1-modificerede glycopeptider
FI941149A7 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
KR950700297A (ko) 5-HT3-수용체 길항제로서의 2,6-메타노-2H-퀴놀리진 유도체(2,6-Methano-2H-quinolizin derivative as 5-HT3-receptor antagonist)
HN1997000013A (es) Compuestos 1,4 dihidropiridina
BR9408162A (pt) Derivados de ácido 2,3,5,6-tetrafluorbenzóico
ITTO920528A1 (it) Fondo di calzatura.
BR9612409A (pt) 1,2,4,6-Tiatriazinas substituídas úteis como herbididas
IT1267343B1 (it) Composizione insetticida.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application